AgeX Therapeutics, Inc. (AGE)

SG&A Expenses

$2.97M

Quarterly · Period ending: · USD

AGE logo

AGE SG&A Expenses

Latest reported$2.97M
AGE Quarterly SG&A Expenses ($1.29M → $2.97M)
High-resolution chart · PNG

AGE sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
2,968,000
3,081,000
2,806,000
2,741,000
2,543,000
2,907,000
2,799,000
2,911,000
2,323,000
1,220,000
3,433,000
2,172,000
1,730,000
1,993,000
1,581,000
1,392,000
1,338,000
1,660,000
1,517,000
1,421,000
1,748,000
2,022,000
1,728,000
1,949,000
1,653,000
2,073,000
1,717,000
2,194,000
2,119,000
2,109,000
1,968,000
1,254,000
1,135,000
1,290,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.